Advisors Capital Management’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.7M Buy
1,859,275
+110,013
+6% +$2.3M 0.41% 74
2026
Q1
$36.6M Buy
1,749,262
+85,144
+5% +$1.8M 0.43% 76
2025
Q4
$35.2M Buy
1,664,118
+90,697
+6% +$1.92M 0.41% 73
2025
Q3
$33.4M Buy
1,573,421
+118,681
+8% +$2.5M 0.41% 71
2025
Q2
$30.6M Buy
1,454,740
+126,136
+9% +$2.6M 0.42% 75
2025
Q1
$27.6M Buy
1,328,604
+99,645
+8% +$2.04M 0.43% 72
2024
Q4
$25M Buy
1,228,959
+596,179
+94% +$12.3M 0.39% 76
2024
Q3
$13.4M Buy
632,780
+28,760
+5% +$600K 0.22% 130
2024
Q2
$12.3M Buy
604,020
+61,720
+11% +$1.25M 0.21% 131
2024
Q1
$11.1M Buy
+542,300
New +$11.1M 0.2% 129

Other funds holding IBDW

Advisors Capital Management's IBDW Position: Q2 2026 in Review

Advisors Capital Management increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 6.3% in Q2 2026, buying an estimated $2.3M and bringing the position to 1,859,275 shares worth $38.7M. The position accounts for 0.41% of the portfolio, ranked #74.

Advisors Capital Management first reported a position in IBDW in Q1 2024 and has held it in 10 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Advisors Capital Management held 1,859,275 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $38.7M as of Q2 2026.
  • Advisors Capital Management bought 110,013 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $2.3M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.41% of Advisors Capital Management's portfolio in Q2 2026, its #74 holding.
  • Advisors Capital Management first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.